A Spontaneous Model for Autoimmune Myocarditis Using the Human MHC Molecule HLA-DQ81

Genome-wide analyses have shown that the MHC class II region is the principal locus that confers susceptibility to a number of human autoimmune diseases. Due to the high degree of linkage disequilibrium across the MHC, it has been difficult to dissect the contribution of individual genes to disease susceptibility. As a result, intensive efforts have been made to generate mice transgenic for human class II molecules as models of autoimmune disease. However, in every case, additional manipulations—such as immunization with Ag in adjuvant, expression of immunostimulants on target tissues, or coexpression of TCR transgenes—have been required to induce disease. In this study, we show that expression of the human HLA-DQ8 (DQA1*0301/DQB1*0302) molecule alone in three lines of transgenic nonobese diabetic murine class II-deficient (mII−/−) mice results in the spontaneous development of autoimmune myocarditis. The disease shares key features of human myocarditis and was characterized by lymphocytic infiltrates in the myocardium and cardiac myocyte destruction, circulating IgG autoantibodies against cardiac myosin heavy chain, and premature death due to heart failure. We demonstrate that myocarditis could be transferred into healthy HLA-DQ8+RAG-1−/−mII−/− nonobese diabetic recipients with lymphocytes, but not sera. It has been widely thought that autoimmune myocarditis is of infectious etiology, with the immune responses arising secondary to cardiac damage from pathogens. These studies provide direct experimental evidence that spontaneous autoimmune myocarditis can occur in the absence of infection and that expression of HLA-DQ8 confers susceptibility to this organ-specific autoimmune disease.

[1]  Jorma Ilonen,et al.  Prevalence of Celiac disease among children in Finland. , 2003, The New England journal of medicine.

[2]  G. Thiene,et al.  Immunosuppressive Therapy for Active Lymphocytic Myocarditis: Virological and Immunologic Profile of Responders Versus Nonresponders , 2003, Circulation.

[3]  L. Fugger,et al.  A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor , 1999, Nature Genetics.

[4]  E. Thorsby,et al.  EVIDENCE FOR A PRIMARY ASSOCIATION OF CELIAC DISEASE TO A PARTICULAR HLA-DQ a/ß HETERODIMER , 2003 .

[5]  Christophe Benoist,et al.  β-Cell death during progression to diabetes , 2001, Nature.

[6]  G. Nepom,et al.  HLA-DQB1 codon 57 is critical for peptide binding and recognition , 1996, The Journal of experimental medicine.

[7]  John B Carlin,et al.  The epidemiology of childhood cardiomyopathy in Australia. , 2003, The New England journal of medicine.

[8]  K. Wucherpfennig,et al.  Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes , 2000, European journal of immunology.

[9]  S. Schiaffino,et al.  Identification of aand 1-Cardiac Myosin Heavy Chain Isoforms as Major Autoantigens in Dilated Cardiomyopathy , 2005 .

[10]  R. Liberthson,et al.  Sudden death from cardiac causes in children and young adults. , 1996, The New England journal of medicine.

[11]  S. Collins,et al.  T cell-mediated exocrine pancreatic damage in major histocompatibility complex class II-deficient mice. , 1998, Gastroenterology.

[12]  A. Cooke,et al.  Restriction fragment length polymorphisms in the major histocompatibility complex of the non-obese diabetic mouse. , 1990, Journal of autoimmunity.

[13]  Kunimasa Suzuki,et al.  Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAβ knockout NOD mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Codd,et al.  Idiopathic dilated cardiomyopathy: familial prevalence and HLA distribution. , 1997, Heart.

[15]  N. Rose Viral damage or ‘molecular mimicry’—placing the blame in myocarditis , 2000, Nature Medicine.

[16]  N J Cox,et al.  Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. , 2001, American journal of human genetics.

[17]  D. Kioussis,et al.  Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice. , 1998, The Journal of clinical investigation.

[18]  J. Penninger,et al.  Chlamydia infections and heart disease linked through antigenic mimicry. , 1999, Science.

[19]  Don C. Wiley,et al.  Structure of a human insulin peptide–HLA-DQ8 complex and susceptibility to type 1 diabetes , 2001, Nature Immunology.

[20]  Susumu Tonegawa,et al.  RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.

[21]  P. Allen,et al.  Myosin-induced acute myocarditis is a T cell-mediated disease. , 1991, Journal of immunology.

[22]  G. Weir,et al.  Insulin-secreting non-islet cells are resistant to autoimmune destruction. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Benoist,et al.  Major histocompatibility complex class I molecules are required for the development of insulitis in non‐obese diabetic mice , 1993, European journal of immunology.

[24]  V. E. Williams,et al.  Several mechanisms can account for defective E alpha gene expression in different mouse haplotypes. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Todd,et al.  HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus , 1987, Nature.

[26]  H. Luthra,et al.  HLA-DQ6/8 double transgenic mice develop auricular chondritis following type II collagen immunization: a model for human relapsing polychondritis. , 1998, Journal of immunology.

[27]  W. Edwards,et al.  Myocarditis. A histopathologic definition and classification. , 1987, The American journal of cardiovascular pathology.

[28]  J. Todd,et al.  Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. , 2001, Immunity.

[29]  A. Maseri,et al.  Celiac Disease Associated With Autoimmune Myocarditis , 2002, Circulation.

[30]  A. Saxon,et al.  The Autoimmune Diseases, 3rd edition , 1999 .

[31]  Yoshimasa Tanaka,et al.  Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice , 2003, Nature Medicine.

[32]  P. Bedossa,et al.  Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic mice , 1991, Nature.

[33]  P. Anversa,et al.  A matter of life and death: cardiac myocyte apoptosis and regeneration. , 2003, The Journal of clinical investigation.

[34]  MJ Grusby,et al.  Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice , 1991, Science.

[35]  John A Todd,et al.  Genetic Analysis of Autoimmune Disease , 1996, Cell.

[36]  E John Orav,et al.  The incidence of pediatric cardiomyopathy in two regions of the United States. , 2003, The New England journal of medicine.

[37]  T. Okazaki,et al.  Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. , 2001, Science.

[38]  S. Bonner-Weir,et al.  Dynamics of β-cell Mass in the Growing Rat Pancreas: Estimation With a Simple Mathematical Model , 1995, Diabetes.

[39]  K. Sell,et al.  Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis. , 1990, Journal of the American College of Cardiology.

[40]  B. McManus,et al.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. , 1995, The New England journal of medicine.

[41]  L. Leinwand,et al.  Full-length rat alpha and beta cardiac myosin heavy chain sequences. Comparisons suggest a molecular basis for functional differences. , 1989, Journal of molecular biology.

[42]  B. Strauer,et al.  Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. , 1994, Journal of the American College of Cardiology.

[43]  W. Mckenna,et al.  Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. , 1992, Circulation.

[44]  H. Luthra,et al.  HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis , 1996, The Journal of experimental medicine.

[45]  L. Wen,et al.  In Vivo Evidence for the Contribution of Human Histocompatibility Leukocyte Antigen (Hla)-Dq Molecules to the Development of Diabetes , 2000, The Journal of experimental medicine.

[46]  A. Jevnikar,et al.  Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice. , 1999, Diabetes.

[47]  A. Woods,et al.  Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. , 1998, Journal of immunology.

[48]  E. Thorsby,et al.  Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer , 1989, The Journal of experimental medicine.

[49]  H. Weiner,et al.  Cutting edge: homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in nonobese diabetic mice. , 1999, Journal of immunology.

[50]  Luc J. Smink,et al.  Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease , 2003, Nature.

[51]  C. Auffray,et al.  Gene organization of DC and DX subregions of the human major histocompatibility complex. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[52]  L. Mestroni,et al.  Evidence from family studies for autoimmunity in dilated cardiomyopathy , 1994, The Lancet.

[53]  P. Allen,et al.  Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[54]  L. Fugger,et al.  Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[55]  T. Behrens,et al.  Delineating the genetic basis of systemic lupus erythematosus. , 2001, Immunity.